AU6083980A - Monacolin k derivatives - Google Patents

Monacolin k derivatives

Info

Publication number
AU6083980A
AU6083980A AU60839/80A AU6083980A AU6083980A AU 6083980 A AU6083980 A AU 6083980A AU 60839/80 A AU60839/80 A AU 60839/80A AU 6083980 A AU6083980 A AU 6083980A AU 6083980 A AU6083980 A AU 6083980A
Authority
AU
Australia
Prior art keywords
monacolin
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU60839/80A
Other languages
English (en)
Inventor
Kiyoshi Hamano
Seigo Iwado
Masao Kuroda
Sadao Sato
Kazuhiko Tanzawa
Akira Terahara
Yoshio Tsujita
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sankyo Co Ltd
Original Assignee
Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP9581479A external-priority patent/JPS5621594A/ja
Priority claimed from JP12346179A external-priority patent/JPS5646841A/ja
Application filed by Sankyo Co Ltd filed Critical Sankyo Co Ltd
Publication of AU6083980A publication Critical patent/AU6083980A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C59/40—Unsaturated compounds
    • C07C59/42—Unsaturated compounds containing hydroxy or O-metal groups
    • C07C59/46—Unsaturated compounds containing hydroxy or O-metal groups containing rings other than six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
    • C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
    • C07C69/732—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids of unsaturated hydroxy carboxylic acids
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02E—REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
    • Y02E50/00—Technologies for the production of fuel of non-fossil origin
    • Y02E50/10—Biofuels, e.g. bio-diesel

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU60839/80A 1979-07-27 1980-07-28 Monacolin k derivatives Abandoned AU6083980A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP9581479 1979-07-27
JP9581479A JPS5621594A (en) 1979-07-27 1979-07-27 Mb-530b carboxylic acid metal salt and its preparation
JP12346179 1979-09-26
JP12346179A JPS5646841A (en) 1979-09-26 1979-09-26 Mb-530b carboxylic acid ester and its preparation

Publications (1)

Publication Number Publication Date
AU6083980A true AU6083980A (en) 1981-01-29

Family

ID=26436995

Family Applications (1)

Application Number Title Priority Date Filing Date
AU60839/80A Abandoned AU6083980A (en) 1979-07-27 1980-07-28 Monacolin k derivatives

Country Status (16)

Country Link
AT (1) AT375334B (enrdf_load_html_response)
AU (1) AU6083980A (enrdf_load_html_response)
CH (1) CH647749A5 (enrdf_load_html_response)
DD (1) DD153827A5 (enrdf_load_html_response)
DE (1) DE3028284A1 (enrdf_load_html_response)
DK (1) DK322380A (enrdf_load_html_response)
ES (1) ES493726A0 (enrdf_load_html_response)
FI (1) FI71300C (enrdf_load_html_response)
FR (1) FR2462417A1 (enrdf_load_html_response)
GB (1) GB2055100A (enrdf_load_html_response)
IT (1) IT1147763B (enrdf_load_html_response)
NL (1) NL8004303A (enrdf_load_html_response)
NO (1) NO156210C (enrdf_load_html_response)
NZ (1) NZ194445A (enrdf_load_html_response)
PL (1) PL225901A1 (enrdf_load_html_response)
SE (1) SE445828B (enrdf_load_html_response)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1327360C (en) * 1983-11-14 1994-03-01 William F. Hoffman Oxo-analogs of mevinolin-like antihypercholesterolemic agents
DE3580863D1 (de) * 1984-06-04 1991-01-24 Merck & Co Inc Herstellungsverfahren von hemmstoffen der hmg-coa-reduktase mit einer 3,5-dihydroxypentanoatteilstruktur.
EP0204287A3 (en) * 1985-06-04 1987-07-01 Merck & Co. Inc. Process for the preparation of hmg-coa reductase inhibitors with a 3,5-dihydroxypentanoate subunit
USRE33033E (en) * 1985-07-05 1989-08-22 Merck & Co., Inc. Process for the preparation of HMG-CoA reductase inhibitors intermediates
US4611081A (en) * 1985-07-05 1986-09-09 Merck & Co., Inc. Process for the preparation of HMG-CoA reductase inhibitors intermediates
US7238348B2 (en) 1996-09-30 2007-07-03 Beijing Peking University Wbl Corporation Ltd. Method of treatment of osteoporosis with compositions of red rice fermentation products
US6046022A (en) 1996-09-30 2000-04-04 Peking University Methods and compositions employing red rice fermentation products
JP2002518448A (ja) * 1998-06-24 2002-06-25 メルク エンド カムパニー インコーポレーテッド 高血中コレステロールを治療する組成物および方法
SI20070A (sl) 1998-09-18 2000-04-30 LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. Nove soli inhibitorjev HMG-CoA reduktaze
SK16982002A3 (sk) * 2000-06-09 2003-04-01 Lek Pharmaceuticals D. D. Stabilizovaná farmaceuticky účinná kompozícia a liečivý prípravok túto kompozíciu obsahujúci
US6806290B2 (en) 2000-06-09 2004-10-19 Lek Pharmaceuticals D.D. Stabilized pharmaceutically effective composition and pharmaceutical formulation comprising the same
CA2421018A1 (en) * 2000-09-06 2002-03-14 Merck & Co., Inc. Dihydroxy open-acid salt of simvastatin
EA200400034A1 (ru) 2001-06-13 2004-06-24 Ранбакси Лабораторис Лимитед МЕТИЛОВЫЕ АНАЛОГИ СИМВАСТАТИНА В КАЧЕСТВЕ НОВЫХ ИНГИБИТОРОВ HMG-CoA РЕДУКТАЗЫ
KR100379075B1 (en) 2002-03-07 2003-04-08 Jinis Biopharmaceuticals Co Method for producing low cholesterol animal food product and food product therefrom
US8158362B2 (en) 2005-03-30 2012-04-17 Decode Genetics Ehf. Methods of diagnosing susceptibility to myocardial infarction and screening for an LTA4H haplotype

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2748825C2 (de) * 1976-11-02 1986-11-27 Sankyo Co., Ltd., Tokio/Tokyo Substituierte 3,5-Dihydroxyheptansäurederivate und diese enthaltende Arzneimittel gegen Hyperlipämie
JPS55150898A (en) * 1979-05-11 1980-11-25 Sankyo Co Ltd Preparation of a new physiologically active substance mb-530b

Also Published As

Publication number Publication date
SE445828B (sv) 1986-07-21
FR2462417B1 (enrdf_load_html_response) 1984-01-20
NO802244L (no) 1981-01-28
GB2055100A (en) 1981-02-25
CH647749A5 (de) 1985-02-15
ATA392380A (de) 1983-12-15
DK322380A (da) 1981-01-28
SE8005386L (sv) 1981-01-28
NO156210B (no) 1987-05-04
NO156210C (no) 1987-08-12
FR2462417A1 (fr) 1981-02-13
IT8068211A0 (it) 1980-07-28
NZ194445A (en) 1984-07-06
FI71300B (fi) 1986-09-09
DD153827A5 (de) 1982-02-03
FI802357A7 (fi) 1981-01-28
FI71300C (fi) 1986-12-19
ES8105781A1 (es) 1981-06-16
IT1147763B (it) 1986-11-26
NL8004303A (nl) 1981-01-29
PL225901A1 (enrdf_load_html_response) 1982-07-19
DE3028284C2 (enrdf_load_html_response) 1990-08-09
DE3028284A1 (de) 1981-02-19
ES493726A0 (es) 1981-06-16
AT375334B (de) 1984-07-25

Similar Documents

Publication Publication Date Title
AU534647B2 (en) Monacolin k
AU533566B2 (en) Aminoalkylbenzene derivatives
AU538841B2 (en) Quindine derivatives
AU542537B2 (en) Nor-tropane derivatives
AU547149B2 (en) 3-aminopropoxy - indole derivatives
AU516325B2 (en) Spiro-imidazolidinedione derivatives
AU529742B2 (en) Alkyl-ketohexopyranoside derivatives
AU6083980A (en) Monacolin k derivatives
AU534806B2 (en) 3-vinyl-cephalosporin derivatives
AU547872B2 (en) Tripeptidic derivatives
AU538138B2 (en) Methylene-cycloamine derivatives
AU533797B2 (en) Thioethylamide derivatives
AU526214B2 (en) Pteridin derivatives
AU5379279A (en) Glycerylphosphoryl derivatives
AU5649780A (en) Biphosphite derivatives
AU538139B2 (en) 3-methyleneazetidine derivatives
AU536369B2 (en) Pyranone derivatives
AU530761B2 (en) Halo-vincamone derivatives
AU533484B2 (en) Tetrahydrochinoline derivatives
AU538028B2 (en) 1-oxadethiacephalosporin derivatives
AU6235780A (en) Pyridazopyridazine derivatives
AU534308B2 (en) 15-hydroxyimino-e-homo-eburnane derivatives
AU5681180A (en) 2-phenyl-4-pyrone derivatives
AU518068B2 (en) 15-sulfonamidoprostaglandin derivatives
AU543045B2 (en) 1-phenethylimidazole derivatives